Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.28

+5.3%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: OldAIMGuy who wrote (10151)	1/27/2004 3:14:12 PM
From: OldAIMGuy	Read Replies (1) of 52153

Hi RH, (oops, I meant to post this to Richard Harmon) Right around the first of the year Genome Therapeutics announced they were looking at merging with Genesoft Pharmaceuticals. This really lit a fire under the stock. I've owned this company's stock since the mid-1980s, and have periodically harvested some nice profits from stock sales. Recently, with the strength, I've been selling portions of my holding. aim-users.com The stock seems to be under accumulation even as the price rises. stockcharts.com[h,a]dahlyyay[dd][pb50!b200][vc60][iLk14!Lf14]&pref=G Best regards, Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next